Entheon Biomedical Corp. (ENTBF)

0.0226 0.0000 (0.00%) At close: 11:59AM EDT

Entheon Biomedical Corp.

999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada
604-562-3932
https://www.entheonbiomedical.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Timothy Ko	Pres, CEO & Director	97.26k	N/A	1986
Dr. Andrew Peter Hegle Ph.D.	Chief Science Officer, Director of Operations & Director	87.26k	N/A	1979
Mr. Soo-Whan Kim	Interim Chief Financial Officer	N/A	N/A	N/A
Dr. Brian E. Jahns Pharm.D.	Chief Bus. Officer	N/A	N/A	N/A
Ms. Kelly Pladson	Corp. Sec.	N/A	N/A	1983

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Corporate governance

Entheon Biomedical Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.